In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups
- PMID: 10582608
- DOI: 10.1046/j.1471-4159.1999.0732477.x
In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups
Abstract
To study the effects of creatine (Cr) on brain energy metabolism and on hypoxia-induced seizures, 5- to 30-day-old rabbit pups were given subcutaneous Cr (3 g/kg) for 3 days before exposure to 4% O2 for 8 min. In saline-treated controls, hypoxic seizures were most frequent at 15 days (80% of pups) and 20 days (60%) of age. Seizures were prevented at 15 days and reduced 60% at 20 days in Cr-treated pups. In surface coil-localized brain 31P nuclear magnetic resonance spectra, with signal from both cerebral gray (GM) and white (WM) matter, the phosphocreatine (PCr)/nucleoside triphosphate (NTP) ratio doubled between 5 and 30 days of age in controls. In all Cr-injected pups, brain PCr/NTP increased to values seen in 30-day-old controls. When spectra were acquired in predominantly GM and WM slices in vivo, the PCr/NTP ratio was very low in GM at 5 days but reached adult levels by 15 days in controls. In WM, the ratio increased steadily from 5 to 30 days of age. In Cr-injected pups, PCr/NTP increased to mature levels in WM and in GM at all ages. In conclusion, hypoxic seizures occur midway in the time course of brain PCr/NTP increase in rabbit pups as previously described in rat pups. In both altricial pups, systemic Cr increases brain PCr/NTP ratio and prevents hypoxic seizures. These results suggest that mature levels of PCr and/or Cr in brain limit EEG activation either directly or indirectly by preventing hypoxic metabolic changes.
Similar articles
-
In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures.Brain Res. 1998 Feb 2;783(1):19-27. doi: 10.1016/s0006-8993(97)01268-7. Brain Res. 1998. PMID: 9479037
-
Creatine increases survival and suppresses seizures in the hypoxic immature rat.Pediatr Res. 1998 Sep;44(3):410-4. doi: 10.1203/00006450-199809000-00024. Pediatr Res. 1998. PMID: 9727722
-
Brain creatine kinase and creatine transporter proteins in normal and creatine-treated rabbit pups.Dev Neurosci. 2000 Sep-Dec;22(5-6):437-43. doi: 10.1159/000017473. Dev Neurosci. 2000. PMID: 11111160
-
In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog.Am J Physiol. 1997 May;272(5 Pt 1):C1567-77. doi: 10.1152/ajpcell.1997.272.5.C1567. Am J Physiol. 1997. PMID: 9176148
-
Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage.Amino Acids. 2002;23(1-3):221-9. doi: 10.1007/s00726-001-0133-3. Amino Acids. 2002. PMID: 12373542 Review.
Cited by
-
Acute hypoxia increases the cerebral metabolic rate - a magnetic resonance imaging study.J Cereb Blood Flow Metab. 2016 Jun;36(6):1046-58. doi: 10.1177/0271678X15606460. Epub 2015 Oct 2. J Cereb Blood Flow Metab. 2016. PMID: 26661163 Free PMC article.
-
Metabolic parameters of epilepsy: adjuncts to established antiepileptic drug therapy.Neurochem Res. 2003 Feb;28(2):353-65. doi: 10.1023/a:1022433421761. Neurochem Res. 2003. PMID: 12608709 Review.
-
Assessing Creatine Supplementation for Neuroprotection against Perinatal Hypoxic-Ischaemic Encephalopathy: A Systematic Review of Perinatal and Adult Pre-Clinical Studies.Cells. 2021 Oct 27;10(11):2902. doi: 10.3390/cells10112902. Cells. 2021. PMID: 34831126 Free PMC article.
-
Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro.Neurochem Res. 2003 May;28(5):771-7. doi: 10.1023/a:1022874103630. Neurochem Res. 2003. PMID: 12716029
-
Creatine pretreatment protects cortical axons from energy depletion in vitro.Neurobiol Dis. 2012 Aug;47(2):184-93. doi: 10.1016/j.nbd.2012.03.037. Epub 2012 Apr 11. Neurobiol Dis. 2012. PMID: 22521466 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical